Personalis to Present at the Stifel 2024 Healthcare Conference
2024年11月6日 - 6:01AM
ビジネスワイヤ（英語）
Personalis, Inc. (Nasdaq: PSNL), a leader in advanced genomics
for precision oncology, announced today that its management team
will present at the Stifel 2024 Healthcare Conference on Tuesday,
November 19, at 10:55 a.m. Eastern Time in New York, NY at the
Lotte New York Palace Hotel.
About Personalis, Inc.
At Personalis, we are transforming the active management of
cancer through breakthrough personalized testing. We aim to drive a
new paradigm for cancer management, guiding care from biopsy
through the life of the patient. Our highly sensitive assays
combine tumor-and-normal profiling with proprietary algorithms to
deliver advanced insights even as cancer evolves over time. Our
products are designed to detect minimal residual disease (MRD) and
recurrence at the earliest timepoints, enable the selection of
targeted therapies based on ultra-comprehensive genomic profiling,
and enhance biomarker strategy for drug development. Personalis is
based in Fremont, California. To learn more, visit
www.personalis.com and connect with us on LinkedIn and X
(Twitter).
View source
version on businesswire.com: https://www.businesswire.com/news/home/20241105986994/en/
Investors: Caroline Corner investors@personalis.com
415-202-5678
Media: pr@personalis.com
Personalis (NASDAQ:PSNL)
過去 株価チャート
から 11 2024 まで 12 2024
Personalis (NASDAQ:PSNL)
過去 株価チャート
から 12 2023 まで 12 2024
